Article
PNPLA3 and IL 28B signature for predicting susceptibility to chronic hepatitis C infection and fibrosis progression.
Archives of physiology and biochemistry - 1 Apr 2022
Youssef Samar Samir, Abbas Eman Abd El Razek, Youness Rana Ahmed, Elemeery Moustafa Nouh, Nasr Amal Soliman, Seif Sameh
Abstract excerpt
BACKGROUND: Association studies identified genetic polymorphisms as predictive risk factors of rapid fibrosis progression in chronic hepatitis C (CHC). This study aims to assess the impact of IL28B rs8099917 polymorphism on CHC genotype 4 (G4) susceptibility and liver fibrosis progression individually; and in combination with PNPLA3 rs738409. PATIENTS AND METHODS: IL28B rs8099917 and PNPLA3 rs738409 were...
Read the complete abstract on PubMed